dextrothyroxine has been researched along with acetazolamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Alwasel, SH; Atasever, A; Gülçin, İ; Kose, LP; Özdemir, H; Supuran, CT | 1 |
| Freeman, PR; Horowitz, RI | 1 |
3 other study(ies) available for dextrothyroxine and acetazolamide
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
The effects of some avermectins on bovine carbonic anhydrase enzyme.
Topics: Acetazolamide; Animals; Antiparasitic Agents; Carbonic Anhydrases; Cattle; Disaccharides; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Erythrocytes; Ivermectin; Macrolides; Molecular Structure | 2016 |
Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials.
Topics: Acetazolamide; Anti-Inflammatory Agents; Anticoagulants; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Diet Therapy; Humans; Immune System; Inflammation; Ivermectin; Mass Screening; NF-E2-Related Factor 2; NF-kappa B; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Resource Allocation; Risk; Sildenafil Citrate; Treatment Outcome | 2020 |